Ignite Summit | 2021| Learnings from the Covid-19 pandemic to accelerate medical innovation
The Covid-19 crisis has had a seismic impact on the medical innovation ecosystem. A vaccine developed in
nine months, transformation in the delivery of medical appointments and mass testing have demonstrated the
power of the UK’s health science system in tackling the worst global pandemic in a century.
Looking ahead the following areas were identified at the IGNITE summit as key game changers to help UK medical innovation to flourish:
- Urgent breaking down of barriers in collaborative science, from devolved leadership to interdisciplinary
awareness. - Intervention across the innovation pathway to cultivate an entrepreneurial culture, from responding
positively to failure, to innovation governance and alignment of incentives. - A precise focus on needs awareness: accurate identification and articulation of unmet need in health
and social care and optimising industry input. - State-supported life sciences cluster development to attract industry and external investment in medical
innovation. - A focus on the Medicines and Healthcare Products Regulatory Agency (MHRA) in a post-Brexit era as a
force to drive innovation.
The full report shares the learning from four days of intensive discussion with the aim to help the UK
develop and pursue transformative actions the pandemic has highlighted so that, where appropriate,
they can be applied to other fields
Learnings from the Covid-19 pandemic to accelerate medical innovation